Detalles de la búsqueda
1.
Blood-Based Next-Generation Sequencing in Adrenocortical Carcinoma.
Oncologist
; 27(6): 462-468, 2022 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35462410
2.
Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
Oncologist
; 26(10): e1742-e1750, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34156726
3.
Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors.
Oncologist
; 26(12): 1017-1025, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34342095
4.
Clinical benefits of above-standard dose of octreotide LAR in patients with neuroendocrine tumors for control of carcinoid syndrome symptoms: a multicenter retrospective chart review study.
Oncologist
; 19(9): 930-6, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25096997
5.
Metastatic Clear-Cell Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors: Therapies and Ongoing Trials.
Cancers (Basel)
; 14(12)2022 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35740533
6.
Durable complete response for oligometastatic renal cell carcinoma with immune checkpoint inhibition and cytoreductive nephrectomy in a Jehovah's witness: A case report.
Front Oncol
; 12: 949400, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36530969
7.
Analysis of Toxicity and Clinical Outcomes in Full Versus Reduced Starting Dose Cabozantinib in Metastatic Renal Cell Carcinoma Patients.
Clin Genitourin Cancer
; 20(1): 53-59, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34922840
8.
Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience.
J Immunother Precis Oncol
; 5(3): 52-57, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36034580
9.
Symptomatic methemoglobinemia in a patient with metastatic clear cell renal cell carcinoma treated with pembrolizumab and axitinib combination therapy: a case report.
J Med Case Rep
; 15(1): 72, 2021 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33602288
10.
Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade.
Front Oncol
; 11: 701345, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34222024
11.
Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinib.
Cancer Treat Res Commun
; 28: 100393, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34029879
12.
Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors.
Front Oncol
; 11: 707050, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34307176
13.
BRAF V600E mutations: a series of case reports in patients with non-small cell lung cancer.
Cancer Genet
; 208(6): 351-4, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26066373
14.
The Role of Chemotherapy in Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors.
Front Horm Res
; 44: 239-47, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26303716
15.
Vaccine immunotherapy in lung cancer: Clinical experience and future directions.
Pharmacol Ther
; 153: 1-9, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25989231
16.
Above-Label Doses of Octreotide-LAR in Patients With Metastatic Small Intestinal Carcinoid Tumors.
Gastrointest Cancer Res
; 6(3): 81-5, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23936548
Resultados
1 -
16
de 16
1
Próxima >
>>